SECTOR:

CNS

FUND/VEHICLE:

NFLS Direct Investment

INVESTMENT DATE:

2018

GEOGRAPHY:

North America

STATUS CURRENT/FORMER INVESTMENT:

Existing

WEBSITE:

Navitor’s mission is to discover and develop a new class of medicines that restore normal activity to mTORC1 to treat age-related diseases and improve human health.